InvestorsHub Logo
Followers 14
Posts 2863
Boards Moderated 0
Alias Born 12/23/2014

Re: bigpike post# 141

Wednesday, 02/05/2020 4:39:28 PM

Wednesday, February 05, 2020 4:39:28 PM

Post# of 461
BUYOUT?? DOUBTFUL! UNLESS

I do not see a buyout this calendar year. UNLESS Joe Manko/Horton Management wants a buyout and that I very much doubt. Craig-Hallum raised the target price for the shares to $8. Manko and company would want over $10/share.

Dark clouds/black swan events are always a possibility. A surprise verdict in the EDEM case in the Californian courts? A lot of the subcutaneous infusion drugs are plasma derived and there are always possibilities of shortages or contamination issues?

More realistically I suspect that some of the newer cancer therapies will migrate to subcutaneous infusions? Why?? See link hyping subq infusions. Sometimes a story tells more then a narrative!!

https://lamberteatonnews.com/2020/01/29/subcutaneous-treatment-immunoglobulin-g-igg-ivig/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KRMD News